Principal
CurrentTherapeutics investor at inaugural TCG Labs Fund I. TCG Labs-Soleil is a new venture model from The Column Group that blends investors and R&D operations under one roof with a focus on products rather than platforms, and M&A rather than IPO. Our goal is to develop therapies to human proof-of-concept as efficiently as possible.